Endocarditis Prevention Advice Audit Arend A,

Endocarditis Prevention Advice Audit Arend A,
1 / 1
Endocarditis Prevention Advice Audit Arend A, - slide 1 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 2 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 3 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 4 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 5 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 6 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 7 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 8 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 9 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 10 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 11 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 12 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 13 of 14 Endocarditis Prevention Advice Audit Arend A, - slide 14 of 14
Endocarditis Prevention Advice Audit Arend A, Yeong M September 2017 Patients at risk of developing endocarditis Acquired valvular heart disease with stenosis or regurgitation Hypertrophic cardiomyopathy Previous infective endocarditis

Related Topics

Download this presentation From Below

"Endocarditis Prevention Advice Audit Arend A," is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Presentation Transcript

01
Endocarditis Prevention Advice Audit Arend A, Yeong M
September 2017<br>
02
Patients at risk of developing endocarditis*
Acquired valvular heart disease with stenosis or regurgitation
Hypertrophic cardiomyopathy
Previous infective endocarditis
Structural congenital heart disease, including surgically corrected or palliated structural conditions, but excluding isolated atrial septal defects, fully repaired ventricular septal defects or fully repaired patent ductus arteriosus, and closure devices that are judged to be endothelialised
Valve replacement

Vital to provide clear and consistent advice regarding endocarditis prevention to these patients. Background *nice.org.uk/guidance/cg64<br>
03
To assess the compliance with providing clear and consistent information regarding endocarditis prevention in the cardiology clinic letters to patients at risk of developing endocarditis . Audit Aim<br>